IPOPI Position Statement
by Lauren
Posted on May 17, 2018
Details of the IPOPI position statement regarding access to immunoglobulin therapies for patients living with a primary immunodeficiency can be found here: IPOPI-2018-Position-Statement
by Lauren
Posted on May 17, 2018
Details of the IPOPI position statement regarding access to immunoglobulin therapies for patients living with a primary immunodeficiency can be found here: IPOPI-2018-Position-Statement
by Lauren
Posted on May 8, 2018
IPOPI are seeking the input of patients living with primary immunodeficiency and parents who are taking care of a child with a primary immunodeficiency (under the age of 18 years), using IG replacement therapy who have switched to another brand or mode of administration (intravenous, subcutaneous, facilitated subcutaneous) during the last 2 years. The survey…
by Lauren
Posted on April 17, 2018
Safety, Acceptance, Fairness, and Equality (SAFE Project): Acceptable Risk and Donor Selection This study, conducted by researchers at McGill University and the University of Nottingham (funded by the Canadian Blood Services), seeks to better understand people’s attitudes related to blood donation and the current limits on accepting blood from men-who-have-sex-with-men (MSM). In recent years, the…
by Lauren
Posted on April 13, 2018
April 10th, 2018 Update on Immune Globulin Products in Canada Dear CIPO member, Since late 2017 we have been updating our membership in regards to changes to certain immune globulin products. We know that some of you have voiced your concern about how these changes will affect you and your care. Over the last six…